Video Shorts

1:18
Pharma 50: The Trends Behind the Numbers
14 hours ago
by
Michael Christel

1:28
Market Movers RX: Regeneron and McKesson Lead Gainers
15 hours ago
by
Nicholas Jacobus

0:51
The Secret Equation for AI Trust
3 days ago
by
Mike Hollan(+1 more)

0:41
Why Patients Will Use Peptides Regardless of FDA Status
3 days ago
by
Nicholas Jacobus(+1 more)

1:31
Exec on Execs: Compliance Burdens
5 days ago
by
Mike Hollan

1:21
Market Movers RX: Eli Lilly Shares Drop
8 days ago
by
Nicholas Jacobus

0:54
Why Global Science Innovation is Shifting to Asia
9 days ago
by
Mike Hollan(+1 more)

1:29
Exec on Execs: Identifying the Gaps
12 days ago
by
Mike Hollan

1:22
Market Movers RX: Gilead Sciences Leads Gainers
15 days ago
by
Nicholas Jacobus

0:57
Targeted Resilience: A Smarter Tariff Response
16 days ago
by
Nicholas Jacobus(+1 more)

0:52
The 340B Drug Pricing Secret
17 days ago
by
Mike Hollan(+1 more)

2:23
Exec on Execs: Fixing What's Broken
19 days ago
by
Mike Hollan

1:32
Market Movers RX: Moderna Leads Gainers
22 days ago
by
Nicholas Jacobus

0:55
Why Multiple Databases Are Killing Your Business Efficiency
24 days ago
by
Mike Hollan(+1 more)

1:34
Exec on Execs: An Industry Facing Change
a month ago
by
Mike Hollan

0:56
Biotech Security: A New National Defense Priority
a month ago
by
Mike Hollan(+1 more)

1:29
Exec on Execs: China's Rise in Biotech Investment
a month ago
by
Mike Hollan

1:13
Market Movers Rx: Iqvia Leads Gainers
a month ago
by
Nicholas Jacobus

1:53
Execs on Exec: GLP-1 Coverage Gaps, China's Supply Chain, and the Clinical Trial Competitiveness Problem
a month ago
by
Mike Hollan

1:03
Why U.S. Biotech Regulation is Slow
a month ago
by
Mike Hollan(+1 more)

1:19
Market Movers Rx: AbbVie Leads Gainers
a month ago
by
Nicholas Jacobus

0:50
Why Your GLP-1 Strategy Is Failing
a month ago
by
Mike Hollan(+1 more)

0:46
Why U.S. Manufacturing is Losing Its Competitive Edge
2 months ago
by
Nicholas Jacobus(+1 more)

0:54
Why We Need Better Drugs, Not Just More Drugs
2 months ago
by
Mike Hollan(+1 more)

1:21
Market Watch RX: Gilead Joins Top Gainers
2 months ago
by
Nicholas Jacobus

0:27
The Key to AI Scale-Up
2 months ago
by
Michael Christel(+1 more)

1:14
Market Watch Rx: Zoetis Shares Slid
2 months ago
by
Nicholas Jacobus

0:51
The Billions Invested in Domestic Manufacturing
2 months ago
by
Mike Hollan(+1 more)

0:56
Big FDA & EMA Changes for Rare Disease Therapies
2 months ago
by
Mike Hollan(+1 more)

0:53
The Challenges Bringing Pharma and Biotech Manufacturing Back to the U.S.
2 months ago
by
Mike Hollan(+1 more)
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
3
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
4
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
5
